Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study
about
Emerging therapeutic targets in esophageal adenocarcinomaSignaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionBile acids initiate lineage-addicted gastroesophageal tumorigenesis by suppressing the EGF receptor-AKT axis.The role of obesity in oesophageal cancer development.Pathophysiological mechanisms linking obesity and esophageal adenocarcinomamiR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction.In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma.Barrett's esophagus: where do we stand?Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth.Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.Reduced Risk of Barrett's Esophagus in Statin Users: Case-Control Study and Meta-Analysis.AKT plays a crucial role in gastric cancer.Effects of Different Ratio of n-6/n-3 Polyunsaturated Fatty Acids on the PI3K/Akt Pathway in Rats with Reflux Esophagitis.Acetic acid effects on aging in budding yeast: are they relevant to aging in higher eukaryotes?Statins in esophageal cancer cell lines: promising lead?FOXO1: Another avenue for treating digestive malignancy?Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.
P2860
Q26751209-6913351E-4AE0-4EFD-B642-1EF590BE3CE0Q27026253-04C5E9FC-0918-4C60-BABC-28B9E994369EQ33610075-84351C4C-67B9-4F82-B1EF-DE5B0C3ECECFQ34418740-9962047C-5353-44A3-8444-3EE5E8927672Q34508880-DF0EFF4F-F3E6-49DC-A4DF-A40B68A9EDC4Q34670849-EAB1E9A5-3841-4F43-A30C-E87D7310E91DQ35073431-5ED44943-A4F5-48E3-A3E0-D9DDDD92FE11Q35140953-D8269E1F-D16A-4304-809C-4CADBBE42D56Q37243629-2F4E8877-2066-434B-AA15-6B615533FF78Q39383614-1964654B-A5C3-448E-BFD9-C25CB6487A15Q39997801-C0D0C135-E3C2-43C7-B0C6-827162B0159EQ40522077-875850B3-3C70-4083-8FB3-55F94F363C7EQ40888426-5AB75485-6179-46F5-9013-996466B24489Q41786470-375E4D74-EA67-4924-BA0B-AF52152659FCQ43077970-86D097FD-F35F-4C1B-8E6C-C3644FE575E8Q46678846-DD25103E-F9A3-436E-B3AB-7B4015B321DCQ47613328-D02EB9D4-C35E-4FD5-BDA3-6EFEAB624426Q54940434-83B8B48A-176E-432C-853C-572B2160032C
P2860
Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Activation of Akt is increased ...... hological and functional study
@ast
Activation of Akt is increased ...... hological and functional study
@en
Activation of Akt is increased ...... ological and functional study.
@nl
type
label
Activation of Akt is increased ...... hological and functional study
@ast
Activation of Akt is increased ...... hological and functional study
@en
Activation of Akt is increased ...... ological and functional study.
@nl
prefLabel
Activation of Akt is increased ...... hological and functional study
@ast
Activation of Akt is increased ...... hological and functional study
@en
Activation of Akt is increased ...... ological and functional study.
@nl
P2093
P2860
P356
P1433
P1476
Activation of Akt is increased ...... hological and functional study
@en
P2093
Ewen Cameron
Gabriel Mutungi
Ian L P Beales
Khalid El-Amin
Mark Wilkinson
P2860
P2888
P356
10.1186/1471-2407-7-97
P407
P577
2007-06-08T00:00:00Z
P5875
P6179
1020993289